Stockreport

Why Viking Therapeutics (VKTX) Is Down 6.5% After Publishing VK2735 Phase 2 Obesity Trial Results And What's Next [Yahoo! Finance]

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com
PDF in a Phase 2 trial, meeting primary and secondary endpoints and supporting progression into the large Phase 3 VANQUISH-1 study with about 4,650 patients enrolled. The [Read more]